results biopharma - Robuta Search

https://www.biopharmadive.com/news/merck-google-idvynso-roche-fenebrutinib-arcus-gilead-ray/817987/ Merck adds to pharma’s AI push; Roche details MS drug results | BioPharma Dive Merck is making a $1 billion investment in a deal with Google Cloud. Elsewhere, Roche pitched its case for a closely watched multiple sclerosis pill and Arcus... ai push ms drug results biopharma merck adds https://www.biopharmadive.com/news/sanofi-tolebrutinib-multiple-sclerosis-study-results/725852/ Sanofi finds a silver lining in mixed MS drug results | BioPharma Dive Tolebrutinib, which Sanofi acquired in a $3.7 billion deal, failed two studies in people with relapsing disease, but succeeded in a type of multiple sclerosis... silver lining ms drug results biopharma sanofi finds https://www.biopharmadive.com/news/fda-tavneos-erasca-revolution-rocket-voucher-janux/818517/ FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results | BioPharma... Tavneos’ original developer hid a study analysis and then altered data, the FDA alleged. Elsewhere, Erasca’s RAS drug was met with skepticism and Rocket Pharma... drug data slides despite results biopharma fda claims